Skip to main content
. Author manuscript; available in PMC: 2016 Feb 10.
Published in final edited form as: J Clin Immunol. 2015 Feb 10;35(2):100–107. doi: 10.1007/s10875-015-0130-z

Table 1.

Characteristics of individual Coronin-1A deficient patients, listed within sibships, and findings common to all 7 cases.

Feature1 New Patient P7 (this report) Previous published reports Common findings
P1 [5,6] P2, P3, P4 [7] P5, P6 [18,19]
Age at immune evaluation, sex 14 mo F 15 mo F P2, 12 mo M; P3, 7.5 mo F; P4, 14 mo F P5, 7 yr F; P6, 7 yr M CID, onset of infections in infancy
Genotype R12L/del16p11 c248delCT/del16p11 V134M/V134M c248delCT/Q360RfsX44 Interstitial del 16p11; recessive variants
Outcome Died of lymphoma prior to HCT2 Alive and well after HCT P2 alive, no HCT; P3 died prior to HCT; P4 died with HCT P5 died with HCT; P6 alive, HCT planned HCT can cure otherwise lethal infections and organ damage
Immunoglobulins (mg/dL)
IgG (762±209) 50 NA3 (on IVIG) Normal Normal Low - normal
IgM (58±23) 151 46 Normal P5 low; P6 normal Low - normal
IgA (50±24) 60 42 Normal P5 low; P6 normal Low - normal
Lymphocyte subsets (cells/uL)
CD3 T (2100–6200) 98 110 Low Low Low
CD4 T (1300–3400) 39 50 Low Low Low
CD8 T (620–2000) 49 30 Low Low Low
CD45RA T Nearly absent Low Low Very low Low
CD45RO T (<65%) 90% NA 98% NA High
TRECs at diagnosis (>33/μl) 2 (normal PCR control) NA NA NA Low
CD19 B (300–2600) 59 410 Low Low Low - normal
CD16/56 NK (>200) 121 340 Normal Low Low - normal
NK cell function Normal NA NA Low Low - normal
Mitogen response (% of normal)
PHA <10% 10–30% Low-normal Low Low - normal
PWM <10% <10% NA Low - normal Low - normal
ConA <10% <10% NA Low Low
Antibody production after vaccination
Tetanus (>0.15 IU/ml) 1.65 0.02 Normal Normal Poor specific antibody responses
H. influenzae B (>1.0 IU/ml) NA 0.7 <1.0 NA
S pneumoniae (serotypes protective) 0 post 13-valent conjugate vaccine NA P2, P3 NA; P4 normal Low - normal
Other studies
Epstein-Barr virus >25,000 copies; EBV+B cell lymphoma at 14 mo NA P4, EBV+ B cell lymphoproliferation, lymphoma at 12 mo P5, stage IV Hodgkin lymphoma and diffuse large B cell lymphoma, both EBV+ Severe EBV infections, early onset EBV+ lymphoma
TCR Vβ High CD8 Vβ5.1 NA P2, high Vβ4; P2 and P4, low TCR diversity Abnormal TCR Limited TCR diversity
1

Normal ranges for ages 12–24 months in parentheses.

2

HCT, hematopoietic cell transplant.

3

NA, not available